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“The suspicions are born of a forgone
era,” said Rose, director of theDukeUniver-
sity Center for Smoking Cessation, who has
received funding over the years from PMI
and Philip Morris USA. “The real enemy is
death and disease caused by smoking,” not
the tobacco industry.
Today, Rose said, his center is funded
exclusively by National Institutes of Health
grants. Still, he said, “I would not hes-
itate to apply for funding from the founda-
tion. The merits of accepting funding to
do public health [research] outweigh
the risks.”
However, recent reports suggest that
long-held suspicions may still be well-
founded. Shortlybefore the foundationwas
formally launched, Reuters News Agency
published an investigation, based on inter-
nal PMI documents, that concluded the
company has been trying to weaken
Framework Convention on Tobacco Con-
trol provisions curbing tobacco use. Ironi-
cally, Yach helped develop the tobacco
control convention, which coordinates
global efforts to combat tobacco use.
Informed Decision
Ina recent JAMAViewpoint,publisheda few
months before the formal launch of Yach’s
foundation, Sandro Galea, MD, DrPH, dean
of the Boston University School of Public
Health, and his coauthor wrote: “Schools
of public health should not acceptmoney if
doing sopushes them tobe something that
is not consistent with their mission to pro-
mote the health of the public.”
However, Galea says he needs more in-
formation about the smoke-free foundation
beforedecidingwhether to signastatement
that his school will not accept its money. “I
thinkallmoneycomeswithconflicts,”hesaid.
“Shouldwetakemoney fromlargeconglom-
erateswherepartoftheirmanufacturinggoes
to building parts of weapons?” To help in-
formhimandhis faculty and students,Galea
said, hehas invitedYachandDaube to speak
at a symposiumon campus in the fall.
As ofmid-June, the foundationhadnot
yet announced the recipients of its first
roundofgrants. “Myguess is that they’rego-
ing to fund some of the zealous supporters
ofe-cigarettesandpeoplewhohaven’t really
worked intenselyon tobacco,” saidMatthew
Myers, president of the Washington, DC–
based Campaign for Tobacco-Free Kids,
which works in about 25 countries around
the world.
While PMI may be developing smoke-
free alternatives, Myers said, he has never
seenthecompanymarketcombustibleciga-
rettes as aggressively as it is now.
“One of my strongest criticisms of the
foundation is theydidnotdemand, as a con-
dition of accepting themoney, a real change
in Philip Morris’s business practices,” Myers
said. “In the absence of Philip Morris agree-
ing todo that, it is obvious that this grant is a
diversiontomake itappear that theyarepart
of the solution, not the problem itself.”
Note: Source references are available through
embedded hyperlinks in the article text online.
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On May 8, the Democratic Repub-lic of Congo (DRC) notified theWor ld Hea l th Organ izat ion
(WHO) of a confirmed outbreak of Ebola
in Bikoro, on the shores of Lake Tumba in
Équateur Province. Ebola in the DRC is not
unexpected. The first-ever identified
Ebola outbreak occurred in the DRC—then
Zaire—in 1976. This is the ninth of DRC’s
outbreaks, which until now have been
confined mainly to rural areas. With high
fatality rates, earlier outbreaks quickly
burned out due to the natural firewall
of remoteness.
Bikoro and a nearby village, Ikoko-
Impenge, are rural, but onMay 16, theWHO
confirmed spread to Mbandaka, home to
1.2 million people. Peter Salama, MD, MPH,
head of the WHO’s Emergencies Program,
called urban spread a game changer that
could spill over porous borders. Lake
Tumba flows to the Congo River, connect-
ing 2 capital cities (Kinshasa, DRC, and
Brazzaville, Republic of the Congo) along
the waterway. The WHO warned that 9
neighboring countries, including the Cen-
tral African Republic, are at high risk.
The DRC outbreak is the WHO’s first
major test since the West African Ebola
epidemic (2013-2016), which infected
28 600 and killed 11 325. Four global
commissions sharply critiqued the WHO’s
response. The agency took 4 to 5 months
after international spread before declaring
a Public Health Emergency of International
Concern (PHEIC) under the International
Health Regulations (IHR). The WHO’s staff-
ing and budget cuts had so badly weak-
ened its capacity for a rapid response and
exhibited such poor coordination of local
and international actors that the epidemic
spun out of control.
This time the WHO’s response has
been swift and comprehensive. It opera-
tionalized the Emergencies Program and
Contingency Fund for Emergencies, 2 cru-
cial WHO reforms in the wake of the 2013-
2016 epidemic. The WHO deployed an
experimental vaccine called rVSV-ZEBOV,
marking a paradigm shift. Director-General
Tedros Adhanom Ghebreyesus and
Dr Salama flew to Bikoro, partnering with
DRC’s Ministry of Health, a powerful sym-
bol of political commitment.
Lessons Learned by the WHO
WHO transformed its work on pandemic
preparedness and response, learning
major lessons:
Declaring a PHEIC Under the IHR. On
May 18, only 2 days after urban spread, the
director-general convened an emergency
committee under the IHR. The committee
decided not to declare a PHEIC but urged
the WHO to be on high alert, promising
to reconvene if the virus spread interna-
tionally. The committee urged against
travel or trade restrictions, which had dev-
astated West Africa during the 2013-2016
Ebola epidemic. The region faces key chal-
lenges: cases in a congested city; multiple
outbreaks in remote, hard-to-reach loca-
tions; health professionals infected, posing
a risk for amplification; and logistical chal-
lenges of poor infrastructure (for example,
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unpaved roads, lack of electricity, and
limited telecommunications). The out-
break’s epicenter is remote and impover-
ished. These factors pose challenges for
surveillance, case detection and confirma-
tion, contact tracing, and access to vaccines
and therapeutics.
EmergencyResponse.Traditionally, the
WHO has been primarily a normative and
technical organization, with weak opera-
tional capacity to respond to health emer-
gencies. The organization quickly activated
its IncidentManagementSystem, created in
the wake of the West African epidemic, to
place responders, equipment, and supplies
on theground,while coordinating local, na-
tional, and international actors. TheWHO’s
Global Outbreak Alert and Response Net-
work and Emergency Medical Teams initia-
tive will offer additional coordination and
technical support.Theorganizationreleased
$2.6million fromthenewcontingency fund
for health emergencies to provide vitally
needed resources. It has empowered the
DRC’s Ministry of Health, while partnering
with international organizations (Gavi, the
Vaccine Alliance; United Nations Children’s
Fund (UNICEF); the International Federa-
tion of Red Cross and Red Crescent Soci-
eties [IFRC]), and civil society (Médecins
SansFrontières). Internationalpartnershave
improved logistics sohealthworkers,medi-
cal equipment, and vaccines can move to
areas of critical need.
Vaccine. The WHO, with partners, has
sent rVSV-ZEBOV vaccine to the DRC.
Merck provided it without charge, while
Gavi donated $1 million for health workers
and logistics. The rVSV-ZEBOV vaccine is
not officially licensed, but the DRC autho-
rized its compassionate use pending regu-
latory approval. It proved highly effective
in trials in Guinea and Sierra Leone toward
the end of the West African epidemic. Sub-
sequent trials in Africa, Europe, and the
United States reinforced the vaccine’s
effectiveness. Marking a turning point, vac-
cination transforms the response from a
strategy of containment to one of preven-
tion and protection. The vaccination cam-
paign targets frontline responders, health
workers, and contacts of infected persons.
Using a “ring” strategy, vaccination creates
a buffer of immune individuals to prevent
virus transmission.
The WHO and the DRC also must
decide whether to approve and deploy
experimental medicines. During the West
Africanepidemic,aidworkersoftengotpref-
erential access to investigational drugs such
asZMapp.Givingpriority to foreignrespond-
ers generated distrust. Another vital lesson
was to give the host country greater own-
ership of medical countermeasures.
Although vaccination could be trans-
formational, the campaign faces enormous
challenges, including surveillance, labora-
tory confirmation, and locating contacts.
Affected populations are difficult to reach
and include diverse ethnic communities
speaking a dozen languages. Vaccine distri-
bution requires cold storage (−70°C to
−80°C), which requires reliable roads, elec-
tricity, and generators. Fostering public
trust is essential, requiring deep under-
standing of local cultures and genuine
listening to community concerns.
Challenges to Emergency
Preparedness
The WHO’s Strategic Response Plan esti-
mates that $26 million is required for DRC
Ebola funding, a target already reached.
The World Bank will distribute money for
the first time from its Pandemic Emergency
Financing Facility. The resources required
to quell this outbreak through proactive
measurespale incomparisontothewellmore
than $3 billion the West African epidemic
cost the global community (see table).
Although the health emergencies program
and contingency fund are innovative
reforms, both are significantly under-
funded. The United States was the top
donor during the West African epidemic,
yet theTrumpadministration isnowseeking
to vastly scale back pandemic prepared-
ness. Member states need to act as stake-
holders in the WHO’s success to ensure
preparedness, but thus far the organization
has been chronically underfunded.
Beyond global governance, robust
national health systems are the foundation
ofglobalhealth security.The IHRrequiresall
states to maintain core health system ca-
pacities, but most have not complied. In-
vesting in health systems is lagging, both
from domestic governments and interna-
tional donors. The Joint External Evalua-
tion to objectively assess health system ca-
pacitieswasanotherpost-Ebola reform,and
has assessed 67 countries. Yet significant
gaps persist, affecting countries’ surveil-
lance and response.
Countries also frequently fail to comply
with IHR recommendations toavoidunnec-
essary quarantines and trade and travel
restrictions, with many disregarding WHO
recommendations during the West African
epidemic. Fearing reductions in travel, tour-
ism, and trade, governments may not rap-
idly report disease outbreaks.
The World Health Assembly recently
underscored the urgency of containing the
DRC outbreak. Beyond expressions of con-
cern, countries must commit to a global
push to implement IHR core capacities,
strengthen health systems, and empower
the WHO.
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US government
a Funding figures as of January 21, 2016. All international
figures are according to the United Nations Office for the
Coordination of Humanitarian Affairs (OCHA) Financial
Tracking Service and are based on international
commitments during 2014, 2015, and to date in 2016.
According to the US government, its figures reflect its
commitments from fiscal years 2014, 2015, and 2016,
which began October 1, 2014, and October 1, 2015, 
respectively.
Source: US Agency for International Development
(USAID) West Africa—ebola outbreak fact sheet, No. 6;
September 17, 2014. https://www.usaid.gov/ebola
/fy14/fs06. Accessed June 12, 2018.
2014-2016 Total Funding for Ebola Virus
Disease Outbreak Responsea
2 396 694 509
United Kingdom 363 798 934
Germany 166 555 655
World Bank 139 598 831
European Commission 118 947 563
France 108 358 081
Sweden 87 372 415
Japan 78 941 052
Canada 78 020 740
Netherlands 72 866 893
Total 3 611 154 673
Humanitarian Funding,
2014-2016, US $
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